IGF2BP3 and hepatocellular carcinoma: Collectively, these results indicate that circRAPGEF1 competes with ASS1 mRNA for binding to IGF2BP3, resulting in the destabilization of ASS1 mRNA and subsequent downregulation of ASS1 expression in HCC cells.